Progyny Newsroom

A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $24 to $31

Moomoo News09:00 ET

Progyny: Growth Potential Acknowledged Amid Execution Concerns – Hold Rating Maintained

TipRanks07:03 ET

Progyny (PGNY) Gets a Buy From Barclays

TipRanks04:51 ET

Progyny's Growth Trajectory and Market Differentiation Affirm Buy Rating

TipRanks00:32 ET

Progyny Analyst Ratings

BenzingaAug 8 05:47 ET

Progyny Price Target Cut to $31.00/Share From $36.00 by JMP Securities

Dow JonesAug 7 17:03 ET

Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY)

TipRanksAug 7 08:22 ET

Progyny Hold Rating: Adjusted Price Target and Concerns Over Uncertain Growth Trajectory

TipRanksAug 7 06:43 ET

Progyny Analyst Ratings

BenzingaAug 7 06:41 ET

Leerink Partners Downgrades Progyny to Market Perform, Lowers Price Target to $25

BenzingaAug 7 06:40 ET

Barclays Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 7 04:33 ET

JMP Securities Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $31

Moomoo NewsAug 7 00:31 ET

Progyny's Resilience and Growth Prospects Affirmed With Buy Rating Despite Near-Term Challenges

TipRanksAug 7 00:28 ET

Barclays Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 6 06:33 ET

Barclays Keeps Their Buy Rating on Progyny (PGNY)

TipRanksAug 6 05:50 ET

Progyny Analyst Ratings

BenzingaJul 16 05:36 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Progyny (PGNY) and Nanosonics Limited (OtherNNCSF)

TipRanksJul 16 01:12 ET

Analysts Are Bullish on Top Healthcare Stocks: Progyny (PGNY), Regeneron (REGN)

TipRanksMay 21 08:20 ET

Barclays Sticks to Its Buy Rating for Progyny (PGNY)

TipRanksMay 20 06:01 ET

Truist Securities Cuts Price Target on Progyny to $37 From $46, Keeps Buy Rating

MT NewswiresMay 17 05:28 ET